Literature DB >> 1677945

Suppressed expression of ICAM-1 and LFA-1 and abrogation of leukocyte collaboration after exposure of human mononuclear leukocytes to respiratory syncytial virus in vitro. Comparison with exposure to influenza virus.

A R Salkind1, J E Nichols, N J Roberts.   

Abstract

Human mononuclear leukocytes (MNL) exposed to respiratory syncytial virus (RSV) produce net IL-1 inhibitor bioactivity with the anticipated consequences of cell cycle arrest, suppressed virus-specific proliferation, and reduced expression of activation markers. These studies were undertaken to investigate effects of exposure and resultant net IL-1 inhibitor activity on the expression of the intercellular adhesion molecule-1 (ICAM-1), and its ligand the lymphocyte function-associated antigen (LFA-1). MNL collected at 1, 4, and 24 h after exposure to influenza virus (which induces net IL-1 bioactivity) showed enhanced expression of ICAM-1 and LFA-1 relative to sham-exposed MNL and exhibited cell clustering. In contrast, exposure to RSV was associated with suppressed expression of both ICAM-1 and LFA-1 and with minimal detectable cell clustering throughout the culture period. Influenza virus-exposed MNL produced significantly more IL-1 and IFN-gamma (which require cell-cell collaboration for optimal production) than did RSV-exposed MNL. These data raise the possibility that exposure of MNL to RSV fails to elicit or blocks the early events necessary for cellular collaboration, contributing to early suppression of the clonal expansion of RSV-specific lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1677945      PMCID: PMC295373          DOI: 10.1172/JCI115332

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  Respiratory syncytial virus. III. Production of illness and clinical observations in adult volunteers.

Authors:  H M KRAVETZ; V KNIGHT; R M CHANOCK; J A MORRIS; K M JOHNSON; D RIFKIND; J P UTZ
Journal:  JAMA       Date:  1961-05-27       Impact factor: 56.272

2.  Respiratory syncytial virus. IV. Correlation of virus shedding, serologic response, and illness in adult volunteers.

Authors:  K M JOHNSON; R M CHANOCK; D RIFKIND; H M KRAVETZ; V KNIGHT
Journal:  JAMA       Date:  1961-05-27       Impact factor: 56.272

3.  The interaction of human macrophages and lymphocytes in the phytohemagglutinin-stimulated production of interferon.

Authors:  L B Epstein; M J Cline; T C Merigan
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

4.  The glomerular permeability determined by dextran clearance using Sephadex gel filtration.

Authors:  C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

5.  T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1.

Authors:  M L Dustin; T A Springer
Journal:  Nature       Date:  1989-10-19       Impact factor: 49.962

6.  Macrophages are required for influenza virus infection of human lymphocytes.

Authors:  D J Mock; F Domurat; N J Roberts; E E Walsh; M R Licht; P Keng
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

7.  Interleukin-1-inhibitor activity induced by respiratory syncytial virus: abrogation of virus-specific and alternate human lymphocyte proliferative responses.

Authors:  A R Salkind; D O McCarthy; J E Nichols; F M Domurat; E E Walsh; N J Roberts
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

8.  Macrophage-lymphocyte interaction. II. Antigen-mediated physical interactions between immune guinea pig lymph node lymphocytes and syngeneic macrophages.

Authors:  P E Lipsky; A S Rosenthal
Journal:  J Exp Med       Date:  1975-01-01       Impact factor: 14.307

9.  Synergistic interaction of macrophages and lymphocytes in antigen-induced transformation of lymphocytes.

Authors:  R C Seeger; J J Oppenheim
Journal:  J Exp Med       Date:  1970-07-01       Impact factor: 14.307

10.  Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus. Respiratory syncytial virus is a potent inducer of inhibitor activity.

Authors:  N J Roberts; A H Prill; T N Mann
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  16 in total

1.  The role of cell surface expression of influenza virus neuraminidase in induction of human lymphocyte apoptosis.

Authors:  Joan E Nichols; Jean A Niles; Elisa H Fleming; Norbert J Roberts
Journal:  Virology       Date:  2019-06-10       Impact factor: 3.616

2.  Interleukin-6⁻¹⁷⁴ and tumor necrosis factor α⁻³⁰⁸ polymorphisms enhance cytokine production by human macrophages exposed to respiratory viruses.

Authors:  Janak A Patel; Sangeeta Nair; Eliana E Ochoa; Ruksana Huda; Norbert J Roberts; Tasnee Chonmaitree
Journal:  J Interferon Cytokine Res       Date:  2010-10-25       Impact factor: 2.607

3.  Multiple cis regulatory elements control RANTES promoter activity in alveolar epithelial cells infected with respiratory syncytial virus.

Authors:  A Casola; R P Garofalo; H Haeberle; T F Elliott; R Lin; M Jamaluddin; A R Brasier
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Induction of intercellular adhesion molecule-1 in human nasal epithelial cells during respiratory syncytial virus infection.

Authors:  Z Matsuzaki; Y Okamoto; N Sarashina; E Ito; K Togawa; I Saito
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

5.  Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity.

Authors:  J R Panuska; R Merolla; N A Rebert; S P Hoffmann; P Tsivitse; N M Cirino; R H Silverman; J A Rankin
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

6.  Effects of human respiratory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza virus on CD4+ T cell activation by dendritic cells.

Authors:  Cyril Le Nouën; Philippa Hillyer; Shirin Munir; Christine C Winter; Thomas McCarty; Alexander Bukreyev; Peter L Collins; Ronald L Rabin; Ursula J Buchholz
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

7.  Reduced activation and proliferation of human lymphocytes exposed to respiratory syncytial virus compared to cells exposed to influenza virus.

Authors:  Elisa H Fleming; Eliana E Ochoa; Joan E Nichols; M Kerry O'Banion; Alan R Salkind; Norbert J Roberts
Journal:  J Med Virol       Date:  2017-09-26       Impact factor: 2.327

8.  Increased Toll-like receptor 4 expression in infants with respiratory syncytial virus bronchiolitis.

Authors:  A Gagro; M Tominac; V Krsulović-Hresić; A Baće; M Matić; V Drazenović; G Mlinarić-Galinović; E Kosor; K Gotovac; I Bolanca; S Batinica; S Rabatić
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

9.  Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3.

Authors:  Cyril Le Nouën; Shirin Munir; Stéphanie Losq; Christine C Winter; Thomas McCarty; David A Stephany; Kevin L Holmes; Alexander Bukreyev; Ronald L Rabin; Peter L Collins; Ursula J Buchholz
Journal:  Virology       Date:  2009-01-06       Impact factor: 3.616

10.  Up-regulation of intercellular adhesion molecule 1 transcription by hepatitis B virus X protein.

Authors:  K Q Hu; C H Yu; J M Vierling
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.